Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Chinese Patent Office
Fuji
Farmers Insurance
Accenture
Queensland Health

Generated: September 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Neuropeptide Y

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for Neuropeptide Y

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Neuropeptide Y ➤ Sign Up Neuropeptide Y-derived peptides University of Copenhagen (Copenhagen K, DK) N.ae butted.stved Hospital (N.ae butted.stved, DK) ➤ Sign Up
Neuropeptide Y ➤ Sign Up Methods for the treatment of kidney fibrosis THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (Boston, MA) ➤ Sign Up
Neuropeptide Y ➤ Sign Up Method using an Y1 receptor activator for treating an anticancer agent-induced nephrotoxic injury KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) ➤ Sign Up
Neuropeptide Y ➤ Sign Up Diagnostic method for diagnosing depression and monitoring therapy effectiveness BRAINLABS B.V. (NL) RIJKSUNIVERSITEIT GRONINGEN (NL) ACADEMISCH ZIEKENHUIS GRONINGEN (NL) ➤ Sign Up
Neuropeptide Y ➤ Sign Up Amantadine, memantine, and rimantadine conjugates and a pharmaceutical composition for treatment of neuronal disorders ➤ Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for Neuropeptide Y

Drugname Country Document Number Estimated Expiration Related US Patent
Neuropeptide Y European Patent Office 2983690 2033-04-10 ➤ Sign Up
Neuropeptide Y World Intellectual Property Organization (WIPO) 2014166497 2033-04-10 ➤ Sign Up
Neuropeptide Y World Intellectual Property Organization (WIPO) 2015138532 2034-03-12 ➤ Sign Up
Neuropeptide Y South Korea 101826208 2036-02-05 ➤ Sign Up
Neuropeptide Y South Korea 20170093550 2036-02-05 ➤ Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
Accenture
AstraZeneca
Merck
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.